41.12  -4.03 (-8.93%)		08-11 12:31
Open: 45.47 High: 45.595 Volume: 1,831,493		Pre. Close: 45.15 Low: 40.6201 Market Cap: 5,458(M)

Short term
Mid term
Targets	6-month :	53.85	1-year :	58.04
Resists	First :	46.1	Second :	49.7
Pivot price	43.41
Supports	First :	40.29	Second :	33.52
MAs	MA(5) :	44.52	MA(20) :	43.66
	MA(100) :	29.76	MA(250) :	19.88
MACD	MACD :	1.1	Signal :	1.6
%K %D	K(14,3) :	39.8	D(3) :	60.4
RSI	RSI(14): 45.7
52-week	High :	49.7	Low :	8.69

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ DFTX ] has closed above bottom band by 7.5%. Bollinger Bands are 24.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	46 - 46.25	46.25 - 46.46
Low:	44.06 - 44.37	44.37 - 44.63
Close:	44.68 - 45.16	45.16 - 45.55

Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.

Mon, 02 Feb 2026
Definium Therapeutics, Inc. Trade Ideas — NASDAQ:DFTX - TradingView

Tue, 20 Jan 2026
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care - Business Wire

Fri, 16 Jan 2026
Mind Medicine (MindMed) Inc. (DFTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Fri, 16 Jan 2026
Mind Medicine (MindMed) Inc. (DFTX) Stock Live Price, Chart & News - CoinCodex

Fri, 16 Jan 2026
MindMed stock soars 73% after InvestingPro’s undervalued call in May 2024 By Investing.com - Investing.com

Tue, 13 Jan 2026
Mind Medicine Inc. will Change its Ticker to DFTX from MNMD - marketscreener.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	133 (M)
Shares Float	107 (M)
Held by Insiders	1.3 (%)
Held by Institutions	76.3 (%)
Shares Short	10,640 (K)
Shares Short P.Month	10,640 (K)

EPS	-2.5
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.68
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-35.8 %
Return on Equity (ttm)	-94.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-145 (M)
Levered Free Cash Flow	-46 (M)

PE Ratio	-16.33
PEG Ratio	0
Price to Book value	15.23
Price to Sales	0
Price to Cash Flow	-37.43

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.